Brief: Lipella Pharmaceuticals Announces Positive Final Results From Phase 2a Study Of LP-10 In Oral Lichen Planus
18/09/2025 13:10
Sept 18 (Reuters) - Lipella Pharmaceuticals Inc LIPO.PK: LIPELLA PHARMACEUTICALS ANNOUNCES POSITIVE FINAL RESULTS FROM PHASE 2A STUDY OF LP-10 IN ORAL LICHEN PLANUS Source text: ID:nGNX2Bvgjq Further company coverage: LIPO.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipella Pharmaceuticals
See all newsBrief: Lipella Pharmaceuticals Says Bankruptcy Court Approves Sale And Asset Purchase Agreement On June 4
Brief: Lipella Pharmaceuticals Inc. Files Voluntary Petitions For Relief Under Chapter 11
Brief: Lipella Pharmaceuticals Announces Positive Final Results From Phase 2a Study Of LP-10 In Oral Lichen Planus
Brief: Lipella Pharmaceuticals Announces Delisting From Nasdaq Capital Market
U.S. STOCKS ON THE MOVE-Marriott International, Coty, Carlyle Group